'김갑성' 기자의 전체기사
-
Reach Surgical's OMNIBOT Performs First Urology Robotic Teles…
Advancing regional collaboration and surgeon training in remote robotic-assisted surgery SINGAPORE, Oct. 13, 2025 -- Reach Surgical, the Surgical Solutions division of Genesis MedTech, has facilitated the completion of two robotic telesurgeries using its OMNIBOT robotic-assisted system. Operating from Reach Surgical Institute (RSI) in Santiago, Dr. Roberto Vilches and Dr. Marcelo Kerkebe remotely performed a radical prostatectomy and a partial nephrectomy on patients at Meds Medical Center. These procedures mark an important milestone in advancing robotic t
- 김갑성 기자
- 2025-10-13 08:00
-
C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partn…
CHENGDU, China, Oct. 11, 2025 -- C-Ray Therapeutics (Chengdu) Co.,Ltd proudly congratulates its strategic partner, Biokin Pharmaceutical, on receiving implied approval from the National Medical Products Administration (NMPA) for the clinical trial application of [177Lu]-BL-ARC001 Injection, the company's first radiopharmaceutical and a Class 1 innovative biologic. This milestone approval marks Biokin's entry into the fast-growing Radiopharmaceutical Drug Conjugate (RDC) field and reinforces its leadership in large-molecule oncology therapies (ADC/GNC/ARC). The company's flagship asset
- 김갑성 기자
- 2025-10-11 20:45
-
Third Indication for Kelun-Biotech's TROP2 ADC Sac-TMT App…
CHENGDU, China, Oct. 11, 2025 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) was approved for marketing by the National Medical Products Administration (NMPA) for its third indication, the treatment of adult patients with epidermal growth factor receptor (EGFR) mutant-positive locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) who progressed after treatm
- 김갑성 기자
- 2025-10-11 17:54
-
Sandstone Easydrip™ Plus Pen Needles Debut in Turkey --…
[ 메디채널 김갑성 기자 ] Large‑platform hexagonal hub (Hextra Tech) offers superior stability and ease of grip; ISO 13485 & CE certified; launched by a leading regional diabetes distributor and 4,000+ pharmacies ISTANBUL, Oct. 11, 2025 -- Sandstone Medical — a SteriLance Medical sub‑brand focused on diabetes self‑injection — today announced the introduction of its Easydrip™ Plus pen needles into the Turkish market through a leading regional diabetes distributor with a nationwide pharmacy network. The launch is already unlocking interest from neighbouring Middle‑East markets.
- 김갑성 기자
- 2025-10-11 15:50
-
健康管理の主導権は自分にある？アジアのトップ医療専門家が「イエス」と回答、その理…
11の国/地域から100人を超えるヘルスケア・リーダーがAPSMI Summitに集まり、ヘルスケアにおける消費者主導のセルフケアを推進します。 サミットでは、回復力のある医療システムを支援するための知識とツールを個人に提供することの重要性が強調されています。 バリ（インドネシア）、2025年10月11日 -- アジア太平洋の[ 메디채널 김갑성 기자 ] 11の国/地域から100人を超えるヘルスケア・リーダーがバリで開催されたAsia Pacific Self-Medication Industry (APSMI) Summit 2025に集まり、同地域のセルフケア・ソリューションを推進しました。 「ヘルスケアにおけるセルフケア：共通のビジョンから共通の行動へ（Self-Care in Healthcare: From Shared Vision to Shared Action）」というテーマで、今回のサミットは、アジア太平洋地域全体で共通の理解を実際的かつ証拠に基づく行動に変える必要性を強調しました。World Health Organization（WHO）によって認められているセルフケアは、個人が健康を維持し、病気を予防し、責任を持って状態を管理する力を与え、コミュニティと医療システムの両方を強化します。
- 김갑성 기자
- 2025-10-11 06:42
-
Roche Collaborates with OASES to Drive Primary Healthcare Tran…
HONG KONG, Oct. 10, 2025 -- Roche announced its strategic collaboration with the Office for Attracting Strategic Enterprises (OASES) to accelerate healthcare innovation and strengthen Hong Kong's role as a leading hub for life sciences and medical technology in the Asia Pacific region. As part of this announcement, Roche will strengthen its presence in Hong Kong over the next five years. The collaboration is a joint effort between its Pharmaceutical and Diagnostics divisions, with each providing distinct perspectives and advantages. This commitment reflects Roche's confidence i
- 김갑성 기자
- 2025-10-10 21:11
-
알라마 바이오사이언스, NULISAqpcr™ BD-pTau217 분석법 출시: 알츠하이머병…
탁월한 민감도와 특이도를 보장하는 혈액 검사 방식의 새로운 분석법이 등장하면서 진일보한 분석법을 개발하기가 수월해질 전망이다. 프리몬트, 캘리포니아주, 2025년 10월 10일 -- 가장 초기에 질병을 발견할 수 있는 정밀 단백질체학 기술을 선도하는 기업인 알라마 바이오사이언스(Alamar Biosciences)가 오늘 NULISAqpcr™ 뇌 유래 인산화 타우(BD-pTau217) 분석법을 출시한다고 발표했다. 혈액 검사만으로 알츠하이머병과 기타 타우병증 연구의 핵심 바이오마커인 BD-pTau217 수치를 측정할 수 있는 획기적인 진전이 이뤄진 것이다. 이 동종 최초의 분석법은 시판 중인 제품 중 유일한 뇌 내 타우 단백질 단일 검사 솔루션으로서, 신경퇴행성 질환 연구의 정확도와 중추신경계 특이성에 대한 새로운 기준을 제시한다. 알라마의 독점 NULISA™ 플랫폼을 기반으로 하는 NULISAqpcr BD-pTau217 분석법에서는 비침습적 방식으로 혈장, 혈청, 건조 혈반 같은 검체를 채취하며, 전례 없는 수준의 민감도와 특이도가 보장된다. 이 분석법을 사용하면 뇌척수액(CSF)을 채취하거나 PET 영상을 촬영할
- 김갑성 기자
- 2025-10-10 19:39
-
Vietnam's Visionary Leaders Redefine Success at the Asia…
HO CHI MINH CITY, Vietnam, Oct. 10, 2025 -- Vietnam's most visionary leaders and trailblazing enterprises took center stage at the Asia Pacific Enterprise Awards (APEA) 2025 Vietnam, held on 9 October 2025 at the GEM Center, Ho Chi Minh City. Organized by leading regional NGO Enterprise Asia, the prestigious awards program honored businesses and business leaders who are reshaping industries, embracing innovation, and driving sustainable growth. With the theme 'Showcasing Future-Ready Enterprises', this year's APEA celebrated organizations and leaders who are future-proofing the
- 김갑성 기자
- 2025-10-10 15:43
-
Berlin Heals Holding AG Successfully Completes Enrollment in…
Completed Enrollment in First-In-Human Phase I study of Less Invasive Approach Expected to Present 6-Month data in 2026 at a major Cardiology Congress Via Less Invasive Approach, more Cardiologists could implant out-patient Additional studies expanding indications and level of evidence are planned next ZUG, Switzerland, Oct. 10, 2025 -- Berlin Heals Holding AG, a leading clinical-stage medical device company focused on revolutionizing the care of Heart Failure with a first of its kind durable treatment, today announced it has completed enrollment in the First-In-Huma
- 김갑성 기자
- 2025-10-10 15:00
-
Health in Your Hands? Asia's Top Health Experts Say 'Yes' an…
[ 메디채널 김갑성 기자 ] Over 100 healthcare leaders from 11 countries/regions convene at APSMI Summit to advance consumer-led self-care in healthcare. The Summit highlights the importance of empowering individuals with knowledge and tools to support resilient health systems. BALI, Indonesia, Oct. 10, 2025 -- More than 100 healthcare leaders from 11 Asia-Pacific countries and regions gathered at the Asia Pacific Self-Medication Industry (APSMI) Summit 2025 in Bali to accelerate self-care solutions for the region. With the theme "Self-Care in Healthcare: From Shared Vis
- 김갑성 기자
- 2025-10-10 14:43
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-12-13_SAT
- Official streaming platform for the Games of the Future Abu Dhabi 2025 powered by ADNOC launches ahead of opening competition 21:57
- フォーミュラ1エティハド航空アブダビグランプリ（Formula 1 Etihad Airways Abu Dhabi Grand Prix）、ヤス島に339,000人のファンを動員 19:05
- SmallRig and FamilyLens Launch Global Family Filmmaking Initiative at 3rd FamilyLens International Film Festival 13:10
- 「FUJIYA」新ビジュアルアイデンティティと「Tenjincho Place」、2025年度台湾ゴールデンピンデザイン賞に輝く 10:47
- ALL CONEC Signs MOU with MINIMAX to Accelerate Global Digital Dental Expansion 08:00
- Introducing CASEKOO Rouge. The Gold Standard. 06:00
- NETMARBLE REVEALS NEW TRAILER FOR THE SEVEN DEADLY SINS: ORIGIN AT THE GAME AWARDS 2025 03:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 12월 13일 23시 40분